Moreover, DSS-treated VDUP1-KO mice exhibited severe colitis, as evidenced by several clinicopathological indicators, including more pronounced weight loss, diarrhea, and rectal bleeding, as well as histological indicators, such as inflammation, epithelial defects, and crypt atrophy. This evidence concerns the gene TXNIP and colitis.